Literature DB >> 22843421

Mechanisms of BRCA1 tumor suppression.

Daniel P Silver1, David M Livingston.   

Abstract

UNLABELLED: The p220 BRCA1 tumor suppressor protein has been implicated in multiple biochemical and biologic functions since its molecular cloning 18 years ago. Here, we discuss those functions most relevant for its tumor-suppressing activities with an emphasis on new findings. In particular, this review focuses on what is known of the activities of those BRCA1-binding partners that have tumor suppressor functions, on the reversion of mutant BRCA1 alleles concomitant with therapy resistance, on insights gained from studies of BRCA1 structure-function relationships, recent findings from animal models, and the potential role of BRCA1 in some nonhereditary tumors. From this information, a more detailed and refined picture of BRCA1 tumor suppression is beginning to emerge. Although key mysteries remain--such as why BRCA1 tumor suppression is focused on carcinomas of the breast and ovary--the pace of discovery is increasing. SIGNIFICANCE: BRCA1 functions as a clinically important classical tumor suppressor in hereditary breast and ovarian cancer; here, we review progress in understanding how BRCA1 operates to suppress tumor formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843421      PMCID: PMC3437262          DOI: 10.1158/2159-8290.CD-12-0221

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  52 in total

1.  BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

Authors:  S B Cantor; D W Bell; S Ganesan; E M Kass; R Drapkin; S Grossman; D C Wahrer; D C Sgroi; W S Lane; D A Haber; D M Livingston
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

2.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

Authors:  Y Wang; D Cortez; P Yazdi; N Neff; S J Elledge; J Qin
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

3.  BRCA1 inhibition of estrogen receptor signaling in transfected cells.

Authors:  S Fan; J Wang; R Yuan; Y Ma; Q Meng; M R Erdos; R G Pestell; F Yuan; K J Auborn; I D Goldberg; E M Rosen
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

4.  Genetic analysis of BRCA1 function in a defined tumor cell line.

Authors:  R Scully; S Ganesan; K Vlasakova; J Chen; M Socolovsky; D M Livingston
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

Review 5.  Prevention and management of hereditary breast cancer.

Authors:  Steven A Narod; Kenneth Offit
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

6.  A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.

Authors:  Jianwei Wang; Qian Sun; Yohei Morita; Hong Jiang; Alexander Gross; André Lechel; Kai Hildner; Luis Miguel Guachalla; Anne Gompf; Daniel Hartmann; Axel Schambach; Torsten Wuestefeld; Daniel Dauch; Hubert Schrezenmeier; Wolf-Karsten Hofmann; Hiromitsu Nakauchi; Zhenyu Ju; Hans A Kestler; Lars Zender; K Lenhard Rudolph
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

7.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

Authors:  Q Zhong; C F Chen; S Li; Y Chen; C C Wang; J Xiao; P L Chen; Z D Sharp; W H Lee
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

8.  BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

Authors:  D A Bochar; L Wang; H Beniya; A Kinev; Y Xue; W S Lane; W Wang; F Kashanchi; R Shiekhattar
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

9.  Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.

Authors:  Szilvia Solyom; Bernadette Aressy; Katri Pylkäs; Jeffrey Patterson-Fortin; Jaana M Hartikainen; Anne Kallioniemi; Saila Kauppila; Jenni Nikkilä; Veli-Matti Kosma; Arto Mannermaa; Roger A Greenberg; Robert Winqvist
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  66 in total

1.  Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.

Authors:  Anosheh Afghahi; Kirsten M Timms; Shaveta Vinayak; Kristin C Jensen; Allison W Kurian; Robert W Carlson; Pei-Jen Chang; Elizabeth Schackmann; Anne-Renee Hartman; James M Ford; Melinda L Telli
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

2.  BRCA1 is a novel regulator of metabolic function in skeletal muscle.

Authors:  Kathryn C Jackson; Eva-Karin Gidlund; Jessica Norrbom; Ana P Valencia; David M Thomson; Rosemary A Schuh; P Darrell Neufer; Espen E Spangenburg
Journal:  J Lipid Res       Date:  2014-02-24       Impact factor: 5.922

3.  Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.

Authors:  Hua Wang; Dongxi Xiang; Ben Liu; Aina He; Helena J Randle; Kelvin Xi Zhang; Anushka Dongre; Norman Sachs; Allison P Clark; Luwei Tao; Qing Chen; Vladimir V Botchkarev; Ying Xie; Ning Dai; Hans Clevers; Zhe Li; David M Livingston
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

4.  BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork.

Authors:  David T Long; Vladimir Joukov; Magda Budzowska; Johannes C Walter
Journal:  Mol Cell       Date:  2014-09-11       Impact factor: 17.970

Review 5.  The current state of molecular testing in the treatment of patients with solid tumors, 2019.

Authors:  Wafik S El-Deiry; Richard M Goldberg; Heinz-Josef Lenz; Anthony F Shields; Geoffrey T Gibney; Antoinette R Tan; Jubilee Brown; Burton Eisenberg; Elisabeth I Heath; Surasak Phuphanich; Edward Kim; Andrew J Brenner; John L Marshall
Journal:  CA Cancer J Clin       Date:  2019-05-22       Impact factor: 508.702

6.  Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice.

Authors:  Yunxian Liu; Leena Hilakivi-Clarke; Yukun Zhang; Xiao Wang; Yuan-Xiang Pan; Jianhua Xuan; Stefanie C Fleck; Daniel R Doerge; William G Helferich
Journal:  Mol Nutr Food Res       Date:  2015-06-26       Impact factor: 5.914

7.  Induced in vivo knockdown of the Brca1 gene in skeletal muscle results in skeletal muscle weakness.

Authors:  Michael D Tarpey; Ana P Valencia; Kathryn C Jackson; Adam J Amorese; Nicholas P Balestrieri; Randall H Renegar; Stephen J P Pratt; Terence E Ryan; Joseph M McClung; Richard M Lovering; Espen E Spangenburg
Journal:  J Physiol       Date:  2018-12-16       Impact factor: 5.182

8.  BRCA1: a missing link in the Fanconi anemia/BRCA pathway.

Authors:  Alan D D'Andrea
Journal:  Cancer Discov       Date:  2013-04       Impact factor: 39.397

9.  Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

Authors:  Melinda L Telli; Kirsten M Timms; Julia Reid; Bryan Hennessy; Gordon B Mills; Kristin C Jensen; Zoltan Szallasi; William T Barry; Eric P Winer; Nadine M Tung; Steven J Isakoff; Paula D Ryan; April Greene-Colozzi; Alexander Gutin; Zaina Sangale; Diana Iliev; Chris Neff; Victor Abkevich; Joshua T Jones; Jerry S Lanchbury; Anne-Renee Hartman; Judy E Garber; James M Ford; Daniel P Silver; Andrea L Richardson
Journal:  Clin Cancer Res       Date:  2016-03-08       Impact factor: 12.531

10.  BRCA1 pathway function in basal-like breast cancer cells.

Authors:  Sarah J Hill; Allison P Clark; Daniel P Silver; David M Livingston
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.